1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL ARACHIDONIC ACID MARKET BY SOURCE TYPE
5.1. Introduction
5.2. Animal-Based
5.3. Plant-Based
6. GLOBAL ARACHIDONIC ACID MARKET BY FORM TYPE
6.1. Introduction
6.2. Dry
6.3. Liquid
7. GLOBAL ARACHIDONIC ACID MARKET BY APPLICATION
7.1. Introduction
7.2. Infant Nutrition
7.3. Dietary Supplements
7.4. Pharmaceuticals
7.5. Others
8. GLOBAL ARACHIDONIC ACID MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Cargill Incorporated
10.2. Cabio Biotech (Wuhan) Co.., Ltd
10.3. Cayman Chemicals
10.4. DSM-Firmenich
10.5. Merck KgaA
10.6. Avanti Research (Croda International Plc.)
10.7. Guangdong Runke Bioengineering Co., Ltd
10.8. Bio-Techne Corporation
10.9. HiMedia Laboratories LLC
10.10. Tokyo Chemical Industry
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES